Geldanamycin, a Naturally Occurring Inhibitor of Hsp90 and a Lead Compound for Medicinal Chemistry
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c01048 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Russell R A Kitson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic and Bioorganic Chemistry, Charles University, Faculty of Pharmacy in Hradec Králové, Akademika Heyrovského 1203, 50005 Hradec K…. Hauptthemen laut MEDLINE: HSP90 Heat-Shock Proteins, Lactams, Macrocyclic, Benzoquinones. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State of Colorado, European Commission, University of Nottingham.
Abstract (Originalsprache)
Geldanamycin remains a driver in the medicinal chemistry of heat shock protein 90 (Hsp90) inhibition, even half a century after its original isolation from nature. This Perspective focuses on the properties of the benzoquinone ring of the natural product that enable a range of functionalization reactions to take place. Therefore, inherent reactivity at C-17, where the methoxy group serves as a vinylogous ester, and at C-19 that demonstrates nucleophilic, enamide-type character toward electrophiles, and also as a conjugate acceptor to react with nucleophiles, has facilitated the synthesis of semisynthetic derivatives. Thus, a range of C-17-substituted amine derivatives has been investigated in oncology applications, with a number of compounds in this series reaching clinical trials. In contrast, the 19-position of geldanamycin has received less attention, although 19-substituted derivatives offer promise with markedly reduced toxicity compared to geldanamycin itself, while retaining Hsp90 inhibitory activity albeit with diminished potency in cellular studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Organic and Bioorganic Chemistry, Charles University, Faculty of Pharmacy in Hradec Králové, Akademika Heyrovského 1203, 50005 Hradec Králové, Czech Republic.
- Datwyler Sealing Technologies CZ Ltd., Polní 224, 50401 Nový Bydžov, Czech Republic.
- Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, 12850 East Montview Boulevard, Aurora, Colorado 80045, United States.
- School of Chemistry, University of Nottingham, University Park, Nottingham NG7 2RD, U.K.
ORCID-Profile: Christopher J Moody
Förderung
- State of Colorado
- European Commission
- University of Nottingham
- Parkinson's UK
- National Institutes of Health
- Grantov? Agentura, Univerzita Karlova
- University of Warwick
- Cancer Research UK
Zitieren
APA
Kitson, R. R. A., Kitsonová, D., Siegel, D., Ross, D., & Moody, C. J. (2024). Geldanamycin, a Naturally Occurring Inhibitor of Hsp90 and a Lead Compound for Medicinal Chemistry. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01048
Vancouver
Kitson RRA, Kitsonová D, Siegel D, Ross D, Moody CJ. Geldanamycin, a Naturally Occurring Inhibitor of Hsp90 and a Lead Compound for Medicinal Chemistry. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01048
BibTeX
@article{Kitson2024,
author = {Kitson, Russell R A and Kitsonová, Dominika and Siegel, David and Ross, David and Moody, Christopher J},
title = {Geldanamycin, a Naturally Occurring Inhibitor of Hsp90 and a Lead Compound for Medicinal Chemistry},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c01048}
}
EUVIMED